Biotech VCs, used to a winning formula in drug development, face disruption The rise of Chinese biotech and promise of AI are suddenly scrambling the industry’s playbook

https://www.statnews.com/2026/04/09/biotech-venture-capital-disruption/ By Allison DeAngelisApril 9, 2026 DeAngelis spoke with about two dozen biotech VCs and limited partners to report this story.